Virtual reality (VR) dosing arm for Cancer Pain

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
MedStar Washington Hospital Center, Washington, United States
Cancer Pain+1 More
Virtual reality experience for 10 minutes - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This is a non-randomized, unblinded dose-titration study to evaluate different "doses" of virtual reality to impact moderate-to-severe pain in patients living with cancer. After consenting to participate, in addition to usual pharmacologic pain management, participants will receive 1 week of VR daily for 10 minutes per session, then 1 week of VR twice a day for 10 minutes per session, then 1 week of VR use as desired by the participants.

Eligible Conditions

  • Cancer Pain
  • Malignancies

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 5 Secondary · Reporting Duration: A) study day 7, B) study day 14, C) study day 21

Day 21
Change in PROMIS Pain Interference Short Form from baseline (Study day 0) to each subsequent measurement (measured on Study day 7, Study day 14, Study day 21)
Change in as-needed opioid doses from baseline (Study day 0) to each subsequent measurement (measured on Study day 7, Study day 14, Study day 21)
Change in satisfaction with overall pain management from baseline (Study day 0) to each subsequent measurement (measured on Study day 7, Study day 14, Study day 21)
Change in self-reported pain score from baseline (Study day 0) to each subsequent measurement (measured on Study day 7, Study day 14, Study day 21)
Day 21
Satisfaction with virtual reality intervention over previous 7 days
Study day 21
Preferences for virtual reality thematic content (measured once, with no comparison)

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Virtual reality (VR) dosing arm
1 of 1
Experimental Treatment

60 Total Participants · 1 Treatment Group

Primary Treatment: Virtual reality (VR) dosing arm · No Placebo Group · N/A

Virtual reality (VR) dosing arm
Device
Experimental Group · 1 Intervention: Virtual reality experience for 10 minutes · Intervention Types: Device

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: a) study day 7, b) study day 14, c) study day 21
Closest Location: MedStar Washington Hospital Center · Washington, United States
Photo of washington  1Photo of washington  2Photo of washington  3
2021First Recorded Clinical Trial
2 TrialsResearching Cancer Pain
101 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have cancer (any type).
You have moderate-severe pain related to cancer or cancer treatment at baseline.
You are able to give informed consent.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.